APA (7th ed.) Citation

N, K., ML, E., Y, S., R, S., R, M., H, S., . . . U, G. (2024). Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies. Advances in therapy, 41(4), 1637. https://doi.org/10.1007/s12325-023-02771-z

Chicago Style (17th ed.) Citation

N, Khera, et al. "Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies." Advances in Therapy 41, no. 4 (2024): 1637. https://doi.org/10.1007/s12325-023-02771-z.

MLA (9th ed.) Citation

N, Khera, et al. "Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies." Advances in Therapy, vol. 41, no. 4, 2024, p. 1637, https://doi.org/10.1007/s12325-023-02771-z.